BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22581667)

  • 1. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity.
    Guillem F; Kannengiesser C; Oudin C; Lenoir A; Matak P; Donadieu J; Isidor B; Méchinaud F; Aguilar-Martinez P; Beaumont C; Vaulont S; Grandchamp B; Nicolas G
    Hum Mutat; 2012 Sep; 33(9):1388-96. PubMed ID: 22581667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.
    Ramsay AJ; Quesada V; Sanchez M; Garabaya C; Sardà MP; Baiget M; Remacha A; Velasco G; López-Otín C
    Hum Mol Genet; 2009 Oct; 18(19):3673-83. PubMed ID: 19592582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematologic data, iron parameters and molecular findings in two new cases of iron-refractory iron deficiency anaemia.
    Tchou I; Diepold M; Pilotto PA; Swinkels D; Neerman-Arbez M; Beris P
    Eur J Haematol; 2009 Dec; 83(6):595-602. PubMed ID: 19708871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA).
    De Falco L; Totaro F; Nai A; Pagani A; Girelli D; Silvestri L; Piscopo C; Campostrini N; Dufour C; Al Manjomi F; Minkov M; Van Vuurden DG; Feliu A; Kattamis A; Camaschella C; Iolascon A
    Hum Mutat; 2010 May; 31(5):E1390-405. PubMed ID: 20232450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iron deficiency anaemia due to a matriptase-2 mutation].
    Cuijpers ML; Wiegerinck ET; Brouwer R; de Witte TJ; Swinkels DW
    Ned Tijdschr Geneeskd; 2010; 154():A1038. PubMed ID: 20719010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6).
    Krijt J; Fujikura Y; Ramsay AJ; Velasco G; Nečas E
    Blood Cells Mol Dis; 2011 Aug; 47(2):133-7. PubMed ID: 21612955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation Gly603Arg of TMPRSS6 in a Korean female with iron-refractory iron deficiency anemia.
    Choi HS; Yang HR; Song SH; Seo JY; Lee KO; Kim HJ
    Pediatr Blood Cancer; 2012 Apr; 58(4):640-2. PubMed ID: 21618415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
    Stirnberg M; Maurer E; Horstmeyer A; Kolp S; Frank S; Bald T; Arenz K; Janzer A; Prager K; Wunderlich P; Walter J; Gütschow M
    Biochem J; 2010 Aug; 430(1):87-95. PubMed ID: 20518742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA.
    Altamura S; D'Alessio F; Selle B; Muckenthaler MU
    Biochem J; 2010 Nov; 431(3):363-71. PubMed ID: 20704562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies.
    De Falco L; Silvestri L; Kannengiesser C; Morán E; Oudin C; Rausa M; Bruno M; Aranda J; Argiles B; Yenicesu I; Falcon-Rodriguez M; Yilmaz-Keskin E; Kocak U; Beaumont C; Camaschella C; Iolascon A; Grandchamp B; Sanchez M
    Hum Mutat; 2014 Nov; 35(11):1321-9. PubMed ID: 25156943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.
    Silvestri L; Guillem F; Pagani A; Nai A; Oudin C; Silva M; Toutain F; Kannengiesser C; Beaumont C; Camaschella C; Grandchamp B
    Blood; 2009 May; 113(22):5605-8. PubMed ID: 19357398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.
    Melis MA; Cau M; Congiu R; Sole G; Barella S; Cao A; Westerman M; Cazzola M; Galanello R
    Haematologica; 2008 Oct; 93(10):1473-9. PubMed ID: 18603562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron-refractory iron deficiency anemia (IRIDA) cases with 2 novel TMPRSS6 mutations.
    Sal E; Keskin EY; Yenicesu I; Bruno M; De Falco L
    Pediatr Hematol Oncol; 2016 Apr; 33(3):226-32. PubMed ID: 27120435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Into the matrix: regulation of the iron regulatory hormone hepcidin by matriptase-2.
    Knutson MD
    Nutr Rev; 2009 May; 67(5):284-8. PubMed ID: 19386032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.
    Silvestri L; Pagani A; Nai A; De Domenico I; Kaplan J; Camaschella C
    Cell Metab; 2008 Dec; 8(6):502-11. PubMed ID: 18976966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of TMPRSS6 gene in Saudi female patients with iron deficiency anemia.
    Al-Jamea LH; Woodman A; Heiba NM; Elshazly SA; Khalaf NB; Fathallah DM; Al-Nashmi ME; Quiambao JV; Deifalla AH
    Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):41-50. PubMed ID: 32446932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2.
    Maurer E; Gütschow M; Stirnberg M
    Biochem J; 2013 Mar; 450(3):583-93. PubMed ID: 23293962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to assess causality of TMPRSS6 mutations?
    Silvestri L; Rausa M; Pagani A; Nai A; Camaschella C
    Hum Mutat; 2013 Jul; 34(7):1043-5. PubMed ID: 23554218
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6.
    Truksa J; Gelbart T; Peng H; Beutler E; Beutler B; Lee P
    Br J Haematol; 2009 Nov; 147(4):571-81. PubMed ID: 19751239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the acronym IRIDA acceptable for slow responders to iron in the presence of TMPRSS6 mutations?
    Yilmaz-Keskin E; Sal E; de Falco L; Bruno M; Iolascon A; Koçak U; Yenicesu I
    Turk J Pediatr; 2013; 55(5):479-84. PubMed ID: 24382527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.